[et_pb_section fb_built=”1″ _builder_version=”4.27.5″ _module_preset=”default” da_disable_devices=”off|off|off” global_colors_info=”{}” custom_padding=”0px|||||” da_is_popup=”off” da_exit_intent=”off” da_has_close=”on” da_alt_close=”off” da_dark_close=”off” da_not_modal=”on” da_is_singular=”off” da_with_loader=”off” da_has_shadow=”on”][et_pb_row _builder_version=”4.27.5″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.27.5″ _module_preset=”default” global_colors_info=”{}”][et_pb_image src=”https:\/\/cardivapt.perseiconsulting.org\/wp-content\/uploads\/2026\/01\/iv-scaled-1.jpg” title_text=”iv-scaled” _builder_version=”4.27.5″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_image][et_pb_text _builder_version=”4.27.5″ _module_preset=”default” global_colors_info=”{}”]Cardiva, a leading Spanish company in technological solutions for the healthcare sector, announces the acquisition of the assets of Overpharma, a leading company in the Portuguese medical technology market. This operation, valued at approximately five million euros, represents a decisive step in Cardiva’s international expansion and reinforces its commitment to innovation, quality and the medical community and patients in healthcare at an international level. <\/p>\n
With this integration, Cardiva will not only maintain the product portfolio it already offered to healthcare professionals in Portugal, but will also expand its offer with new specialties, such as Traumatology and Ophthalmology. This operation consolidates Cardiva as a benchmark supplier of medical technology for hospitals, clinics and healthcare professionals throughout the Iberian Peninsula, bringing advanced solutions to both countries that boost the quality and efficiency of healthcare. <\/p>\n
“This acquisition marks a milestone in our history and reaffirms our vision of growth in the Iberian Peninsula. We want to offer the best innovation in healthcare to more customers and in more locations, and we are delighted to add Overpharma’s assets and experience to this path. This integration will allow us to strengthen our response capacity and optimize the services we provide to health centers in Portugal,” says Ignacio Vega, Cardiva’s chairman<\/strong>. <\/p>\n For her part, Ana Isabel Nunes, director of Cardiva in Portugal<\/strong> and former director of Overpharma, points out that “the incorporation of Overpharma’s assets into Cardiva represents a great opportunity to strengthen access to new solutions in this country. I am convinced that this union will allow our customers and patients to benefit from a high-quality product catalog, adapted to the requirements of our healthcare system. As the new director of Cardiva in Portugal, I am committed to continuing to offer a service that is close, agile and in line with the expectations of healthcare professionals.”[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":" Cardiva, a leading Spanish company in technological solutions for the healthcare sector, announces the acquisition of the assets of Overpharma, a leading company in the Portuguese medical technology market. This operation, valued at approximately five million euros, represents a decisive step in Cardiva’s international expansion and reinforces its commitment to innovation, quality and the medical […]<\/p>\n","protected":false},"author":1,"featured_media":351,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[],"tags":[],"class_list":["post-350","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry"],"_links":{"self":[{"href":"https:\/\/cardivapt.perseiconsulting.org\/en\/wp-json\/wp\/v2\/posts\/350","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cardivapt.perseiconsulting.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cardivapt.perseiconsulting.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cardivapt.perseiconsulting.org\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/cardivapt.perseiconsulting.org\/en\/wp-json\/wp\/v2\/comments?post=350"}],"version-history":[{"count":8,"href":"https:\/\/cardivapt.perseiconsulting.org\/en\/wp-json\/wp\/v2\/posts\/350\/revisions"}],"predecessor-version":[{"id":781,"href":"https:\/\/cardivapt.perseiconsulting.org\/en\/wp-json\/wp\/v2\/posts\/350\/revisions\/781"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cardivapt.perseiconsulting.org\/en\/wp-json\/wp\/v2\/media\/351"}],"wp:attachment":[{"href":"https:\/\/cardivapt.perseiconsulting.org\/en\/wp-json\/wp\/v2\/media?parent=350"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cardivapt.perseiconsulting.org\/en\/wp-json\/wp\/v2\/categories?post=350"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cardivapt.perseiconsulting.org\/en\/wp-json\/wp\/v2\/tags?post=350"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}